The Effects of Acarbose on Non-Diabetic Overweight and Obese Patients: A Meta-Analysis
ConclusionAcarbose monotherapy is beneficial in reducing TG levels in obese or overweight patients and will not result in hypoglycemia during medication. The side effects of acarbose are mild.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Acarbose | Cholesterol | Clinical Trials | Databases & Libraries | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Eating Disorders & Weight Management | Endocrinology | Gastroenterology | Obesity | Science | Statistics | Study | Weight Loss